Literature DB >> 11559369

Processing of natural and recombinant CXCR3-targeting chemokines and implications for biological activity.

P J Hensbergen1, E M van der Raaij-Helmer, R Dijkman, R C van der Schors, G Werner-Felmayer, D M Boorsma, R J Scheper, R Willemze, C P Tensen.   

Abstract

Chemokines comprise a class of peptides with chemotactic activity towards leukocytes. The potency of different chemokines for the same receptor often varies as a result of differences in primary structure. In addition, post-translational modifications have been shown to affect the effectiveness of chemokines. Although in several studies, natural CXCR3-targeting chemokines have been isolated, detailed information about the proteins and their possible modifications is lacking. Using a combination of liquid chromatography and mass spectrometry we studied the protein profile of CXCR3-targeting chemokines expressed by interferon-gamma-stimulated human keratinocytes. The biological implications of one of the identified modifications was studied in more detail using calcium mobilization and chemotaxis assays. We found that the primary structure of human CXCL10 is different from the generally accepted sequence. In addition we identified a C-terminally truncated CXCL10, lacking the last four amino acids. Native CXCL11 was primarily found in its intact mature form but we also found a mass corresponding to an N-terminally truncated human CXCL11, lacking the first two amino acids FP, indicating that this chemokine is a substrate for dipeptidylpeptidase IV. Interestingly, this same truncation was found when we expressed human CXCL11 in Drosophila S2 cells. The biological activity of this truncated form of CXCL11 was greatly reduced, both in calcium mobilization (using CXCR3 expressing CHO cells) as well as its chemotactic activity for CXCR3-expressing T-cells. It is concluded that detailed information on chemokines at the protein level is important to characterize the exact profile of these chemotactic peptides as modifications can severely alter their biological activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559369     DOI: 10.1046/j.0014-2956.2001.02433.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.

Authors:  Vincent Vanheule; Rik Janssens; Daiane Boff; Nikola Kitic; Nele Berghmans; Isabelle Ronsse; Andreas J Kungl; Flavio Almeida Amaral; Mauro Martins Teixeira; Jo Van Damme; Paul Proost; Anneleen Mortier
Journal:  J Biol Chem       Date:  2015-07-16       Impact factor: 5.157

2.  Discrimination of agonist and antagonist forms of CXCL10 in biological samples.

Authors:  A Casrouge; A Bisiaux; L Stephen; M Schmolz; J Mapes; C Pfister; S Pol; V Mallet; M L Albert
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

3.  Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-like protein CCX-CKR.

Authors:  J Vinet; M van Zwam; I M Dijkstra; N Brouwer; H R J van Weering; A Watts; M Meijer; M R Fokkens; V Kannan; D Verzijl; H F Vischer; M J Smit; R Leurs; K Biber; H W G M Boddeke
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

Review 4.  Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26.

Authors:  Mieke Metzemaekers; Jo Van Damme; Anneleen Mortier; Paul Proost
Journal:  Front Immunol       Date:  2016-11-11       Impact factor: 7.561

5.  Glycosaminoglycans Regulate CXCR3 Ligands at Distinct Levels: Protection against Processing by Dipeptidyl Peptidase IV/CD26 and Interference with Receptor Signaling.

Authors:  Mieke Metzemaekers; Anneleen Mortier; Rik Janssens; Daiane Boff; Lotte Vanbrabant; Nicole Lamoen; Jo Van Damme; Mauro M Teixeira; Ingrid De Meester; Flávio A Amaral; Paul Proost
Journal:  Int J Mol Sci       Date:  2017-07-13       Impact factor: 5.923

Review 6.  CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology.

Authors:  Anneleen Mortier; Mieke Gouwy; Jo Van Damme; Paul Proost; Sofie Struyf
Journal:  J Leukoc Biol       Date:  2016-01-07       Impact factor: 4.962

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.